Pharmacie Christine BOVY SRL
Pharmacie Christine BOVY reported total assets of 124,548 € at the end of the 2024 financial year (annual accounts filed with the NBB on 17 Apr 2025).
The score of Pharmacie Christine BOVY shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +291 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 19 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Christine BOVY's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 17 Apr 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
- Year ended 31 Dec 2020filed on 28 Jul 2021
Pharmacie Christine BOVY's financial analysis
- Solvency40.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Christine BOVY
Pharmacie Christine BOVY's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0447.041.425
- VAT number
- BE0447041425
- Peppol
- Registered · 0208:0447041425 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Mar 1992
- Registered office
- 6061 Charleroi
- Latest accounts
- 2024 · filed on 17 Apr 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Christine BOVY (SRL) has been based in Charleroi since 1992, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 27,940 € and equity of 50,484 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Christine BOVY
Companies in the same business, of comparable size and area, outside its group.
- Apotheker Kaat Stas Retail sale of pharmaceutical products Mortsel · balance sheet 123,434 €
- Mont Royal Retail sale of pharmaceutical products Brussels · balance sheet 126,135 €
- Sirona Retail sale of pharmaceutical products Etterbeek · balance sheet 126,289 €
- Pharma Nasir Retail sale of pharmaceutical products Ixelles · balance sheet 126,608 €
- O.Sabur Retail sale of pharmaceutical products Genk · balance sheet 129,423 €
- Medlinx Lina Retail sale of pharmaceutical products Schaerbeek · balance sheet 130,245 €
- Toelen Apotekers Retail sale of pharmaceutical products Halle · balance sheet 118,845 €
- Farma Jana Retail sale of pharmaceutical products Lo-Reninge · balance sheet 118,424 €
Frequently asked questions about Pharmacie Christine BOVY
What is the revenue of Pharmacie Christine BOVY?
Pharmacie Christine BOVY files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Pharmacie Christine BOVY?
In Belgium, the VAT number is the company number prefixed with BE: BE0447041425 for Pharmacie Christine BOVY, if the company is VAT-registered. Its company number (CBE) is 0447.041.425.
Where is the registered office of Pharmacie Christine BOVY?
According to the CBE register, the registered office of Pharmacie Christine BOVY is in 6061 Charleroi.
What is the equity of Pharmacie Christine BOVY?
At the close of the 2024 financial year, the equity of Pharmacie Christine BOVY amounts to 50,484 €, a solvency of 40.5% of total assets.
Who manages Pharmacie Christine BOVY?
The register lists 2 active mandates at Pharmacie Christine BOVY. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Christine BOVY
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →